497 集

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

OncLive® On Air OncLive® On Air

    • 健康與體能

In OncLive® On Air, you can expect to hear interviews with academic oncologists on the thought-provoking oncology presentations they give at the OncLive® State of the Science Summits. The topics in oncology vary, from systemic therapies, surgery, radiation therapy, to emerging therapeutic approaches in a particular type of cancer. This includes lung cancer, breast cancer, gastrointestinal cancers, hematologic malignancies, gynecologic cancers, genitourinary cancers, and more.

    Reckamp Discusses the Integration of Pragmatic Elements Into Oncology Clinical Trial Designs

    Reckamp Discusses the Integration of Pragmatic Elements Into Oncology Clinical Trial Designs

    Dr Reckamp discusses the definition of pragmatic clinical trials and ways that clinical trial investigators can make their research more pragmatic.

    • 9 分鐘
    Rosenberg Reviews the Evolving Role of Toripalimab in Nasopharyngeal Carcinoma

    Rosenberg Reviews the Evolving Role of Toripalimab in Nasopharyngeal Carcinoma

    Dr Rosenberg discusses current standard strategies for treating patients with nasopharyngeal cancer, the evolving role of toripalimab in this treatment paradigm, and how future advances in nasopharyngeal cancer management may impact the head and neck cancer treatment paradigm more broadly.

    • 18 分鐘
    ASCO 2024 Plenary: LAURA Trial in Unresectable Stage III EGFRm NSCLC

    ASCO 2024 Plenary: LAURA Trial in Unresectable Stage III EGFRm NSCLC

    OncLive On Air partners with Two Onc Docs to bring insights on primary data from the LAURA trial, which were presented at the 2024 ASCO Annual Meeting.

    • 12 分鐘
    Paik Provides Insights Into Tepotinib Treatment in NSCLC Harboring MET Exon 14 Skipping Alterations

    Paik Provides Insights Into Tepotinib Treatment in NSCLC Harboring MET Exon 14 Skipping Alterations

    Dr Paik discusses key findings from the phase 2 VISION trial investigating frontline tepotinib in patients with NSCLC harboring MET exon 14 skipping alterations, real-world data from the TOGETHER pooled analysis of tepotinib vs other frontline treatment options in this patient population, and insights regarding treatment sequencing with tepotinib in pretreated patients in this population.

    • 13 分鐘
    Lenz Discusses the Prognostic and Predictive Value of HER2 Gene Expression in KRAS Wild-Type mCRC

    Lenz Discusses the Prognostic and Predictive Value of HER2 Gene Expression in KRAS Wild-Type mCRC

    Lenz discusses the link between HER2 expression and responses with mCRC treatment regimens and how HER2 expression can guide treatment decision-making.

    • 13 分鐘
    Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC

    Levy Lends Insights Into the Current and Future Use of ADCs in NSCLC

    Dr Levy discusses the indication for trastuzumab deruxtecan in HER2+ NSCLC, other ADCs in development, and where the future of ADCs in NSCLC is headed.

    • 10 分鐘

關於健康與體能的熱門 Podcast

Chasing Life
CNN
艾灸养生108招
冯名雨艾灸
健人港人話 Steven Talks
Steven Yu
A Gay and A NonGay
James Barr and Dan Hudson
The Psychology of your 20s
iHeartPodcasts
Relaxed Rachel 放鬆瑞秋
Relaxed Rachel

你可能也會喜歡

ASCO Daily News
American Society of Clinical Oncology (ASCO)
Two Onc Docs
Sam and Karine
Plenary Session
Vinay Prasad, MD MPH
Sensible Medicine
Sensible Medicine Authors - Prasad/Cifu/Mandrola/Demania/Makary/Cristea/Alderighi & More
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine Podcast
NEJM This Week
NEJM Group